Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

New Stock Coverage: Diana Shipping Stuck in Dry Dock


Wall Street ratings agencies set the tone for today's stock market.

When a guy called Stephen King starts issuing scary warnings, one would expect stocks to sink. Yet the market continued its upward march, thanks in part to the Fed's leading lady whose name is straight out of a horror show. Dow Industrials (^DJI) ended at their second highest closing level ever after Ms. Yellen's reassurance of continued easy money outweighed China concerns.

On an iconic anniversary in ballet, Yahoo's (YHOO) Marissa Mayer, a huge fan of the dance, saw her stock surge 3.46% to its best in more than four years on an analyst upgrade. Her former employer Google (GOOG) went one better, reaching an historic peak, which will further sour the mood over at its arch-enemy Apple (AAPL). That stock tumbled 2.42% to fall for a fourth straight session.

If that's enough for suffering shareholders to shoot themselves with a stun gun, well, at least Taser International (TASR) advanced 4.53%. And Otis elevator maker United Technologies (UTX) slid 1.11%, Mr. Market shunning the stock after getting stuck in a lift with all of Modern Family except, worse luck, Sofia Vergara.

Today's main economic data is the Institute for Supply Management's non-manufacturing index for February at 10:00 a.m. Eastern. In earnings action, Deutsche Post (PINK:DPSGY), Smith & Wesson (SWHC), Standard Chartered (PINK:SCBFF), and VeriFone Systems (PAY) are all expected to release results.

Acuity Brands (AYI): The diversified electronics outfit is assigned a Buy at UBS, whose price objective is $76.

Aegerion Pharmaceuticals (AEGR): Bank of America-Merrill Lynch launches coverage at a Buy.

Agilent Technologies (A): Shares are set an Outperform and $48 price target at Credit Suisse.

AG Mortgage Investment Trust (MITT): Credit Suisse has a new Neutral on the real estate name.

Drug Stocks: Jefferies begins Buys on Aegerion Pharmaceuticals (AEGR), Anthera Pharmaceuticals (ANTH), Dyax Corp. (DYAX), and Supernus Pharmaceuticals (SUPN).

E2open (EOPN): Citing both market leadership and a strong management team, Benchmark begins Buy rated research with a $25 objective.

Health Insurance Innovations (HIIQ) Credit Suisse (Outperform) and Bank of America-Merrill Lynch (Buy) are equally upbeat on HIIQ.

Millennial Media (MM): Needham has a Hold on the stock.

New Source Energy (NSLP): Shares are a new Outperform at Robert W. Baird, which establishes a target price of $23 amid an attractive 10.4% current yield and impressive compound production growth prospects.

Sarepta Therapeutics (SRPT): Leerink Swann launches the equity at Outperform.

Shipping Stocks: JPMorgan covers Costamare (NYSE:CMRE) at Overweight and has a new Neutral on Diana Shipping (NYSE:DSX). The respective price objectives are $16.50 and $9.50.

Wright Medical (WMGI): Shares are resumed with an Overweight at JPMorgan.

ZAIS Financial (ZFC): Oppenheimer establishes Perform rated coverage on ZFC, but Barclays (Overweight), Citigroup (Buy), and Credit Suisse (Outperform) are more bullish.

(See also: Stock Upgrades: MGIC Investment Looks Like Magic and Stock Downgrades: Cliffs Natural Resources Still Falling Off a Cliff.)
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos